Eurofins Scientific Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
TMO | Thermo Fisher Scientific | Outperform |
10
|
$572.38 | $591.94 | 8.32% | 1 | $218.49B |
SHL | Siemens Healthineers | Buy |
8
|
51.90€ | 56.34€ | 15.61% | 9 | 57.91€B |
LONN | Lonza Group | Buy |
16
|
CHF519.60 | CHF516.89 | 14.51% | 8 | CHF37.47B |
A | Agilent Technologies | Outperform |
10
|
$139.45 | $138.82 | 8.28% | 10 | $40.87B |
IQV | IQVIA Holdings | Outperform |
15
|
$223.37 | $267.27 | 23.11% | 19 | $40.70B |
ICLR | ICON Public | Buy |
16
|
$309.02 | $306.07 | 16.50% | 1 | $25.55B |
SGSN | SGS | Hold |
18
|
CHF82.36 | CHF86.34 | 9.28% | 7 | CHF15.59B |
603259 | WuXi AppTec | Buy |
18
|
¥43.67 | ¥121.48 | 45.13% | 0 | ¥123.21B |
LH | Laboratory Corp of America Hol... | Outperform |
11
|
$201.32 | $241.28 | 20.21% | 9 | $16.97B |
DGX | Quest Diagnostics | Outperform |
10
|
$137.38 | $141.17 | 5.55% | 8 | $15.26B |
BVI | Bureau Veritas | Outperform |
18
|
27.70€ | 26.96€ | 11.91% | 12 | 12.44€B |
SW | Sodexo | Outperform |
16
|
80.75€ | 114.78€ | 11.46% | 3 | 11.99€B |
BIM | bioMérieux | Outperform |
18
|
98.70€ | 105.55€ | 15.50% | 1 | 11.82€B |
PKI | PerkinElmer | Outperform |
16
|
$100.61 | $121.84 | 23.13% | 1 | $12.49B |
CRL | Charles River Laboratories Int... | Outperform |
16
|
$233.47 | $229.97 | 18.54% | 11 | $11.76B |
NTRA | Natera | Buy |
7
|
$96.98 | $74.41 | 6.72% | 8 | $11.35B |
EXAS | Exact Sciences | Buy |
8
|
$62.07 | $90.32 | 43.72% | 7 | $10.91B |
CTLT | Catalent | Hold |
15
|
$56.50 | $49.29 | 12.39% | 3 | $10.23B |
ITRK | Intertek Group | Outperform |
18
|
£49.56 | £44.87 | 6.54% | 14 | £7.97B |
SHL | Sonic Healthcare | Hold |
18
|
$26.12 | $34.12 | 18.68% | 0 | $12.86B |
BIO | Bio-Rad Laboratories Inc | Outperform |
16
|
$279.83 | $536.80 | 51.88% | 1 | $7.74B |
ADEN | Adecco Group | Hold |
18
|
CHF31.96 | CHF42.09 | 26.03% | 6 | CHF5.40B |
ALQ | ALS | Outperform |
18
|
$13.09 | $12.63 | 1.99% | 9 | $6.35B |
1548 | Genscript Biotech | Buy |
5
|
HK$12.00 | HK$3.96 | -68.00% | 0 | HK$24.72B |
AZTA | Azenta | Hold |
16
|
$53.42 | $58.50 | 19.81% | 5 | $2.93B |
SYNH | Syneos Health | - |
16
|
$42.98 | $43.00 | -100.00% | 0 | $2.64B |
TWST | Twist Bioscience | Outperform |
4
|
$41.21 | $34.00 | 6.77% | 2 | $2.40B |
GH | Guardant Health | Buy |
6
|
$18.88 | $43.00 | 133.05% | 2 | $2.30B |
300676 | BGI Genomics | - |
17
|
¥41.13 | ¥0.00 | -100.00% | 0 | ¥15.61B |
NEO | NeoGenomics | Outperform |
8
|
$15.30 | $20.09 | 24.18% | 9 | $1.95B |
EVT | Evotec | Outperform |
14
|
9.76€ | 37.33€ | 161.27% | 4 | 1.73€B |
MYGN | Myriad Genetics | Hold |
6
|
$19.47 | $22.08 | 28.40% | 8 | $1.77B |
APPS | Applus Services | Outperform |
15
|
12.68€ | 10.92€ | -9.70% | 3 | 1.63€B |
VCYT | Veracyte | Outperform |
11
|
$20.35 | $32.17 | 59.71% | 4 | $1.56B |
OPK | OPKO Health | Outperform |
8
|
$1.01 | $6.70 | 296.04% | 0 | $1.18B |
A096530 | Seegene |
18
|
₩22.35k | ₩25.00k | 11.86% | 0 | ₩1.02T | |
CLB | Core Laboratories | Hold |
16
|
$15.92 | $23.11 | 13.07% | 1 | $741.02M |
FLGT | Fulgent Genetics | Hold |
16
|
$21.50 | $31.50 | 16.28% | 2 | $642.86M |
CDNA | CareDx, Inc | Outperform |
9
|
$9.72 | $11.80 | 33.74% | 1 | $505.52M |
NEOGEN | Neogen Chemicals | Outperform |
14
|
Rp1.54k | Rp1.68k | 11.39% | 3 | Rp40.69B |
1521 | Frontage Holdings | Outperform |
12
|
HK$1.35 | HK$0.29 | -84.44% | 0 | HK$2.49B |
MG | Mistras Group | Outperform |
12
|
$9.45 | $9.50 | 37.57% | 3 | $268.11M |
CDXC | ChromaDex | Buy |
10
|
$3.78 | $4.88 | 58.73% | 4 | $267.30M |
APH | Alliance Pharma | Outperform |
18
|
£0.33 | £0.82 | 81.82% | 2 | £191.84M |
CSBR | Champions Oncology | Hold |
9
|
$5.13 | $8.75 | 16.96% | 0 | $68.78M |
TISI | Team | - |
6
|
$6.92 | $130.00 | -100.00% | 0 | $27.96M |
LXXG.Q | LexaGene Holdings | - |
4
|
$0.11 | $0.75 | -100.00% | 0 | $11.34M |
OPGN | OpGen |
2
|
$0.47 | $3.00 | -100.00% | 1 | $4.61M | |
NVTA | Invitae | - |
4
|
$0.00 | $0.71 | 0.00% | 8 | $3.18M |